Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian P Selinger

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Biologicals are the main contributor to cost of care for IBD: a European perspectiveChristian P Selinger
Journal of Medical Economics|September 23, 2014
How costly is non-adherence to infliximab in patients with Crohn's disease?Christian P Selinger
Alimentary Pharmacology & Therapeutics|February 27, 2020
Letter: increased risk of caesarean section for women with IBD-more questions than answersChristian P Selinger
Southern Medical Journal|September 10, 2009
Celiac disease and the heartChristian P Selinger
Digestive Diseases and Sciences|July 13, 2022
Introduction to the DDS Mini‑Issue: "Inflammatory Bowel Disease and Pregnancy"Christian P Selinger
Journal of Gastrointestinal and Liver Diseases : JGLD|March 25, 2017
Gastric cancer in patients with inflammatory bowel disease: more than just a random association?Christian P Selinger
Digestive Diseases and Sciences|February 11, 2016
SEMS for Palliation of Malignant Colonic Obstruction: Why SEMi Available Is Not Good EnoughChristian P Selinger
Journal of Clinical Medicine|January 21, 2023
Obstetric Considerations in Pregnant Women with Crohn's DiseaseKonstantina Rosiou, Christian P Selinger
Alimentary Pharmacology & Therapeutics|December 28, 2020
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?Isabel Carbery, Christian P Selinger
Expert Review of Gastroenterology & Hepatology|March 20, 2024
IBD in women of reproductive age: where do novel therapies fit in?Melanie Cuffe, Christian P Selinger
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Biologicals are the main contributor to cost of care for IBD: a European perspectiveChristian P Selinger
Journal of Medical Economics|September 23, 2014
How costly is non-adherence to infliximab in patients with Crohn's disease?Christian P Selinger
Alimentary Pharmacology & Therapeutics|February 27, 2020
Letter: increased risk of caesarean section for women with IBD-more questions than answersChristian P Selinger
Southern Medical Journal|September 10, 2009
Celiac disease and the heartChristian P Selinger
Digestive Diseases and Sciences|July 13, 2022
Introduction to the DDS Mini‑Issue: "Inflammatory Bowel Disease and Pregnancy"Christian P Selinger
Journal of Gastrointestinal and Liver Diseases : JGLD|March 25, 2017
Gastric cancer in patients with inflammatory bowel disease: more than just a random association?Christian P Selinger
Digestive Diseases and Sciences|February 11, 2016
SEMS for Palliation of Malignant Colonic Obstruction: Why SEMi Available Is Not Good EnoughChristian P Selinger
Journal of Clinical Medicine|January 21, 2023
Obstetric Considerations in Pregnant Women with Crohn's DiseaseKonstantina Rosiou, Christian P Selinger
Alimentary Pharmacology & Therapeutics|December 28, 2020
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?Isabel Carbery, Christian P Selinger
Expert Review of Gastroenterology & Hepatology|March 20, 2024
IBD in women of reproductive age: where do novel therapies fit in?Melanie Cuffe, Christian P Selinger
Pageof 12